James Cai joined Amgen as Vice President of Regulatory Affairs, Japan Asia Pacific (JAPAC) since May 2014. His focus is to lead and oversee development and implementation of regulatory strategies across multiple countries, which currently includes Australia, China, Japan, India, Malaysia, Singapore, South Korea, Taiwan and Thailand.
Prior to Amgen, Dr. Cai worked for Roche / Genentech as head of Asia Early Phase Clinical Development strategy, Vice President of Medical Affairs Roche China. He worked with AstraZeneca as R&D head China, and with other MNCs including Pfizer and MSD as Medical Director and External Affairs Director respectively.
Dr. Cai is trained as Medical Physician, Clincial Researcher from Shanghai Jiao Tao University Medical School, New York University Medical School, EMBA from Columbia University.